Randomized, Double-Blind, Pilot Study of Nitazoxanide Versus Placebo for the Treatment of Symptoms Associated with Viral Respiratory Infection in Adults and Adolescents.

Trial Profile

Randomized, Double-Blind, Pilot Study of Nitazoxanide Versus Placebo for the Treatment of Symptoms Associated with Viral Respiratory Infection in Adults and Adolescents.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Oct 2011

At a glance

  • Drugs Nitazoxanide (Primary)
  • Indications Influenza virus infections; Respiratory tract infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Oct 2011 New trial record
    • 21 Oct 2011 Results were presented at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) and also in a Romark Laboratories media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top